Sandoz Canada Inc.
Registration:
28
of
33
(2023-01-18
to
2023-04-24)
Senior Officers whose lobbying activities represent less than 20% of their Duties
-
Mauricio Ede,
Chief Medical & Scientific Officer
-
Catherine Rousseau,
Senior director, BioGx Market Access
-
Tracey Stott,
Intellectual Property Director
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
-
Guillaume Lefevre,
Director, Government Affairs
-
Christian Ouellet,
Vice-président Affaires corporatives
- Date Modified: